After years of research and multiple rounds of funding, you are finally ready for the first phase of clinical trials. The competition is fierce, and time is of the essence. Given the number of drugs that don’t survive all phases of development, the odds are against you, but you are determined to succeed. And while you know everything there is about your Investigational Medicinal Product (IMP), you realize that it’s only one small piece of running a successful clinical trial.
Download this whitepaper to learn why sponsors should consider partnering with an organization with demonstrated expertise, ability to work across geographies and cultures, a keen understanding of local and international requirements, and that offer models for support at multiple levels.